Telehealth company Hims & Hers is making its stock market debut Thursday after completing a merger with special purpose acquisition vehicle (SPAC) Oaktree Acquisition Corp.
The San Francisco-based company made its name by offering online consultations and discreet shipping for men's personal care products treating hair loss and erectile dysfunction, but it has since expanded into women's products and a suite of primary care and mental health offerings.
In New York City, the brand's cheeky subway ads have been ubiquitous since the company launched in 2017.
Andrew Dudum, founder and CEO of Hims & Hers, told Cheddar the company is well-positioned to take advantage of the emerging field of telehealth.
"It's just an amazing opportunity to bring great consumer-first access to health care to the masses for $20 to $30 per person," he said. "When you think about the traditional health care system, for most of us, a co-pay on our insurance plan might be $40 or $50 dollars just to see a doctor once."
Hims & Hers' model has powered nearly three million telemedicine consultations since its launch, according to the company. This has fueled a surge in revenue growth amid the coronavirus pandemic, with the company posting a 91 percent year-over-year gain in the third quarter of last year.
Despite these gains, Hims & Hers remains unprofitable, but Dudum said the cost of acquiring new customers is falling as the brand achieves greater awareness among consumers.
"As we get bigger, as people more know of our brand and talk about our brand, our ability to acquire customers at more efficient cost is only getting more improved," he said.
Dudum explained that the company had been exploring a traditional IPO until this year's SPAC boom offered an efficient alternative.
"We decided to go public via SPAC because for so many reasons it was more efficient, more affordable, and a lot more flexible than the traditional IPO process," he said. "The SPAC process takes roughly six months or so to go public, relative to maybe 12 or 18 months with a traditional IPO."
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
A look into how disruption, AI, and global economic trends are transforming the modern supply chain with Jeremy Jansen, Head of Supply Chain at Wells Fargo.
